Hiromichi Iwamura Shingo Hatakeyama Yoshimi Tanaka Toshikazu Tanaka Noriko Tokui Hayato Yamamoto Atsushi Imai Takahiro Yoneyama Yasuhiro Hashimoto Takuya Koie Kazuaki Yoshikawa Chikara Ohyama
10.1186/1756-0500-7-64
BMC Res Notes
2014 Jan 29;7:64.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24476098/
Adenocarcinoma / secondary Biopsy, Needle Bone Neoplasms / secondary Neoplasms, Hormone-Dependent / secondary Neoplasms, Unknown Primary Prostate-Specific Antigen / blood Prostatic Neoplasms / diagnosis
Adenocarcinoma / secondary Biopsy, Needle Bone Neoplasms / secondary Neoplasms, Hormone-Dependent / secondary Neoplasms, Unknown Primary Prostate-Specific Antigen / blood Prostatic Neoplasms / diagnosis Case Reports Research Support, Non-U.S. Gov't Adenocarcinoma / blood Adenocarcinoma / diagnosis Adenocarcinoma / drug therapy Adenocarcinoma / pathology Androgen Antagonists / therapeutic use Antineoplastic Agents, Hormonal / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Back Pain / etiology Bone Neoplasms / blood Bone Neoplasms / diagnosis Bone Neoplasms / drug therapy Bone Neoplasms / pathology Diagnostic Imaging Disseminated Intravascular Coagulation / etiology Docetaxel Drug Resistance, Neoplasm False Negative Reactions Fatal Outcome Humans Male Middle Aged Neoplasms, Hormone-Dependent / blood Neoplasms, Hormone-Dependent / diagnosis Neoplasms, Hormone-Dependent / pathology Prostatic Neoplasms / blood Prostatic Neoplasms / pathology Prostatic Neoplasms / surgery Taxoids / administration & dosage Transurethral Resection of Prostate Androgen Antagonists Antineoplastic Agents, Hormonal Taxoids Docetaxel Prostate-Specific Antigen
PMC3909476
24476098
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy
2014